Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEmerging risk factors and risk markers for cardiovascular disease: Looking beyond NCEP ATP III
Formulary , 08/11/09
Hoffmann TK et al. – Cardiovascular disease continues to be the leading cause of death in the United States. The current standard of care is to treat patients to a target low–density lipoprotein cholesterol level, as recommended by the National Cholesterol Education Program (NCEP) Adult Treatment Panel III. Unfortunately, despite treating patients to their respective LDL goals, many patients continue to suffer cardiovascular events.
Related Articles
Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: A matched-pair cohort study
Arthritis & Rheumatism, 11/05/09
Relevance Score: 71%
Chronic renal insufficiency, cardiovascular disease and mortality in women: a causal relationship or coincidence?
Women's Health, 11/02/09
Relevance Score: 70%
Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmö, Sweden
Rheumatology, 10/30/09
Relevance Score: 70%
Frequency of migraine and the risk of cardiovascular disease for women: limited evidence of an association
Women's Health, 10/30/09
Relevance Score: 69%
Systemic lupus erythematosus and the risk of cardiovascular disease: Results from the Nurses Health Study
Arthritis Care and Research, 10/01/09
Relevance Score: 69%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk
Cleveland Clinic Journal of Medicine, 12/04/09
Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?
Cleveland Clinic Journal of Medicine, 12/04/09
Interferon-gamma (INF-gamma) release test can detect cutaneous adverse effects to statins
International Journal of Dermatology, 12/03/09
Sponsor
Article Search
Sponsor